Medtronic has announced the commercial release of its Reveal LINQ system in Canada, which comes on the heels of a marketing approval for the device in that country. The implantable device, which is more compact than an AAA battery, is used to continuously monitor heart rhythms in patients with irregular heartbeats, unexplained stroke or fainting.

Related Summaries